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Purpose: The aim of this research was to assess the value of the transitional zone index 
(TZI) and intravesical prostatic protrusion (IPP) from transrectal ultrasonography in 
evaluating the severity and progression of disease by analyzing the relationship be-
tween the 2 parameters and symptoms, clinical history, and urodynamics in benign 
prostatic hyperplasia (BPH) patients undergoing different treatment. 
Materials and Methods: A total of 203 patients receiving medication and 162 patients 
who underwent transurethral resection of the prostate because of BPH were enrolled 
in this retrospective analysis. The clinical history and subjective and objective exami-
nation results of all patients were recorded and compared after being classified by TZI 
and IPP level. Linear regression was used to find correlations between IPP, TZI, and 
urodynamics.
Results: The 2 parameters were found to differ significantly between patients receiving 
medication and patients undergoing surgical therapy (p＜0.05). PSA, maximum flow 
rate (Qmax), detrusor pressure at Qmax (PdetQmax), and the bladder outlet ob-
struction index (BOOI) differed according to various TZI levels (p＜0.05). In addition, 
the voiding symptom score, Qmax, and BOOI of subgroups with various IPP levels were 
also significantly different (p＜0.05). Both TZI and IPP had significant effects on Qmax, 
BOOI, and PdetQmax (p＜0.05) and the incidence of acute urinary retention (p=0.000). 
Conclusions: The results demonstrated that both TZI and IPP had favorable value for 
assessing severity and progression in patients with BPH. Further studies are needed 
to confirm whether the two parameters have predictive value in the efficacy of BPH 
treatment and could be considered as factors in the selection of therapy.
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INTRODUCTION 
Benign prostatic hyperplasia (BPH) is found in over half 
of 60-year-old men and in almost all 80-year-old men who 
develop bladder outlet obstruction (BOO) and lower uri-
nary tract symptoms (LUTS) [1]. BOO is the initial patho-
physiological change caused by an enlarged adenoma and 
is followed by detrusor overactivity (DO) or underactivity 
(DUA). The degree of BOO is an important factor that can 
reflect the severity of disease and that can aid in choosing 
a treatment method as well as in measuring the outcome 
of the treatment. It has been shown that one third of male 
patients with LUTS do not have definite BOO and that 5 
to 35% of the patients with LUTS and undefined BOO do 
not have favorable symptom recovery after transurethral 
resection of the prostate (TURP) [2-7]. Relevant examina-
tions ranging from serum prostate-specific antigen (PSA) 
to urodynamics can all reflect different aspects of the se-Korean J Urol 2012;53:253-257
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verity of BPH. Urodynamics is the only method, however, 
that can quantify the degree of BOO and the status of de-
trusor contractility. Therefore, guidelines from the Inter-
national Scientific Committee and the American Urologi-
cal Association on the management of BPH both recom-
mend the use of urodynamics to evaluate BPH patients con-
sidered as candidates for invasive therapy [8]. However, 
the routine use of preoperative urodynamics is still a con-
troversial point in published articles because of the in-
vasiveness and high costs of the method [9]. In this re-
search, we attempted to determine whether other parame-
ters could be used to measure the severity of BOO through 
less-invasive or noninvasive examinations by analyzing 
correlations among parameters from clinical history, 
symptoms, ultrasonography, and urodynamics. 
MATERIALS AND METHODS
This retrospective analysis was conducted on patients with 
BPH who had received either medication or surgical treat-
ment at this hospital between May 2010 and June 2011. 
The therapeutic decision for TURP was based on both clin-
ical assessment and the patient’s desire. All patients were 
evaluated with the International Prostate Symptom Score 
(IPSS, including the total score; subtotal score of storage 
symptoms comprising the summation of nocturia, urgency, 
and an increased frequency score; and subtotal score of 
voiding symptoms comprising the summation of hesitancy, 
intermittency, and weak stream score) and quality of life 
(QoL) questionnaires in addition to undergoing basic clin-
ical evaluations (medical history, physical examination, 
urinalysis, and renal function assessment) before treatment. 
Free flowmetry measurement was performed for all pa-
tients with the result being adopted when the voiding vol-
ume was more than 150 ml. Urodynamics was performed 
only for patients needing surgery by use of a multichannel 
system (UDS64-III, Laborie Co., Quebec, Canada). First, 
water-Filling cystometry was done with the patients in the 
supine position with the use of a transurethral 12 Fr dou-
ble-lumen catheter and the simultaneous monitoring of 
rectal pressure. Filling was performed at a rate of 50 
ml/min with normal saline and was stopped if the patient 
had a strong desire to void. Pressure flow study (PFS) was 
then performed by asking the patients to void in an upright 
position with a suprapubically placed 6 Fr cystostomy tube 
to monitor the bladder pressure. Maximum urinary flow 
(Qmax) and pressure of the detrusor at Qmax (PdetQmax) 
were recorded. The bladder outlet obstruction index 
(BOOI, by “PdetQmax-2Qmax”) and the bladder con-
tractility index (by “PdetQmax+5Qmax”) were then calcu-
lated by use of equations from the ICS [10]. Total prostate 
volume (TPV), transitional zone volume (TZV), intra-
vesical prostatic protrusion (IPP), and post-voiding re-
sidual (PVR) were measured by transrectal ultrasonography 
(TRUS) with the transitional zone index (TZI, by “TZV/TPV”) 
being calculated for all patients. The exclusion criteria for 
enrolled subjects were 1) BOOI less than 20 or Qmax more 
than 20 ml/s, 2) disease with BOO other than BPH, 3) his-
tory of prostatic or urethral surgery, 4) diagnosed carcino-
ma of the prostate or bladder, 5) known bladder stones or 
neurogenic bladder dysfunction, and 6) not having taken 
standard medication involving both alpha-adrenergic 
blockers and 5-alpha-reductase inhibitors for over 6 
months.
The relevant clinical data of the subjects were recorded 
and classified by degree of IPP (＜10 mm, 10 to 20 mm, and 
＞20 mm) and TZI value (＜0.5, 0.5 to 0.7, and ＞0.7). All 
quantitative variables were tested for the type of dis-
tribution by use of the one-sample Kolmogorov-Smirnov 
test. Univariate analyses including one-way analysis of 
variance and Kruskal-Wallis test were used for variables 
with normal or skewed distributions, respectively, to as-
sess the differences between patients receiving drug ther-
apy and those undergoing surgical therapy and between 
patients with different degrees of IPP and TZI values. The 
χ
2-test was used for categorical variables to identify wheth-
er there were different incidences of acute urinary re-
tention (AUR) influenced by different IPP or TZI grade. 
Finally, bivariate correlation and multiple regression 
analysis were used to assess correlations between parame-
ters from TRUS and PFS. All analyses were performed by 
using the routines of the IBM SPSS ver. 19.0 (IBM Co., New 
York, NY, USA), and statistical significance was defined 
as a p-value less than 0.05. The research attained ethical 
approval from the ethics committee of Xin Hua Hospital, 
and all subjects gave written informed consent.
RESULTS 
A total of 365 patients were enrolled in the research study, 
with 203 patients receiving medication and the remainder 
having undergone TURP. The clinical data of all subjects 
were classified according to therapy and degree of IPP and 
TZI and are listed in Tables 1 and 2. Univariate analyses 
showed significant differences in the total, storage, and 
voiding scores of the IPSS; QoL score; TPV; TZV; TZI; IPP; 
and Qmax between the therapy groups (p＜0.05). Baseline 
total prostate-specific antigen, TPV, TZV, IPP, Qmax, 
PdetQmax, and BOOI classified by different degrees of TZI 
were also found to be significantly different (p＜0.05). 
Differences were also found in the voiding symptom score, 
TPV, TZV, TZI, Qmax, and BOOI classified by degree of IPP 
(p＜0.05). IPP (p=0.000) and TZI (p=0.000) both had stat-
istically significant effects on the cause of AUR (Table 2) 
by χ
2-test. The bivariate correlation analysis of parameters 
from symptom score, TRUS, and urodynamics showed sig-
nificant correlations between TZI and Qmax (r=-0.887, 
p=0.001), PdetQmax (r=0.725, p=0.028), and BOOI 
(r=0.508, p=0.029) and between IPP and voiding symptom 
score (r=0.353, p=0.033), Qmax (r=-0.852, p=0.014), and 
BOOI (r=0.469, p=0.042). Multiple regression analysis in 
the subjects who underwent TURP showed that both TZI 
and IPP had significant correlations with Qmax and BOOI, 
whereas TZI had a significant correlation with PdetQmax Korean J Urol 2012;53:253-257
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TABLE 1. Comparisons of baseline characteristics in patients between different methods of therapy
Characteristic Overall (n=365) Medication (n=203) Surgery (n=162) p-value
Age (yr) 66.8±9.4 63.7±5.8 73.3±4.2 0.066
a
T-PSA (ng/ml) 5.1 (0.32-23.9) 4.0 (0.32-9.8) 5.3 (1.4-18.7) 0.146
b
Total IPSS  12.2±7.1   9.3±5.5 18.6±4.1 0.021
a
Storage IPSS   6.9±3.3   6.5±3.4   7.2±7.0 0.053
a
Voiding IPSS   5.8±3.9   3.0±1.8   8.1±4.2 0.007
a
QOL score   3.6±2.6   2.5±1.2   4.1±8.4 0.029
a
TPV (g)   43.0±11.7   36.8±14.5   50.6±27.3 0.012
a
TZV (g)   26.6±19.0   21.5±18.2   35.4±22.7 0.008
a
TZI 0.51±0.8 0.33±0.2 0.62±0.4 0.005
a
IPP (mm) 14.6±8.3 11.2±5.9   17.1±12.0 0.011
a
PVR (ml)   56.5±40.8   30.2±21.7   81.0±54.4 0.000
a
Qmax (ml/s) 10.1±4.8 12.4±6.9   6.9±3.0 0.027
a
PdetQmax (cm H2O)   73.0±40.9   69.4±27.8   83.2±35.5 0.011
a
BOOI    53.5±28.2   43.1±18.4   78.7±36.3 0.024
a
BCI 120.1±36.6 118.4±23.9 126.2±25.0 0.070
a
Presence of AUR history 65 (17.8) 21 (10.3) 44 (27.2) 0.000
c
Values are presented as mean±SD, median (range) or number (%).
T-PSA, total prostate-specific antigen; IPSS, International Prostate Symptom Score; QOL, quality of life; TPV, total prostate volume;
TZV, transitional zone volume; TZI, transitional zone index; IPP, intravesical prostatic protrusion; PRV, postvoiding residual volume; 
Qmax, maximum urinary flow; PdetQmax, pressure of detrusor at Qmax; BOOI, bladder outlet obstruction index; BCI, bladder con-
tractility index; AUR, acute urinary retention.
a: Student’s t-test, 
b: Mann-Whitney U test, 
c: Fisher’s exact test.
TABLE 2. Comparisons of baseline characteristics in patients according to TZI and IPP 
Characteristic TZI IPP
All patients ＜0.5 (n=133) 0.5-0.7 
(n=108)
＞0.7 
(n=124)
p-value ＜10 mm 
(n=110)
10-20 mm 
(n=157)
＞20 mm 
(n=98)
p-value
　Age (yr) 61.3±7.1   63.0±9.27 64.00±8.32 0.291
a 58.6±6.3 63.6±4.9 61.2±7.9 0.240
a
　T-PSA (ng/ml) 3.5 
(0.3-13.3)
4.3 
(2.0-23.9)
7.4 
(6.1-14.1)
0.048
b 4.4 
(0.3-17.1)
3.1 
(0.8-10.3)
5.9 
(4.8-23.9) 
0.072
b
　Total IPSS 11.6±5.9 10.8±8.2 14.2±7.5 0.158
a 12.1±7.3 15.9±6.5 14.8±9.0 0.103
a
　Storage IPSS   6.4±3.7   6.1±4.0     7.2±4.62 0.084
a   5.1±2.2   7.0±4.4   6.8±3.1 0.119
a
　Voiding IPSS   4.2±5.8   6.1±4.5   6.6±3.2 0.055
a   2.8±3.3   5.5±4.2   8.9±5.4 0.008
a
　QOL score   3.1±1.1   2.8±1.3   3.9±1.4 0.106
a   3.7±1.6   4.2±1.4   4.7±1.0 0.379
a
　TPV (g)   29.9±24.1   43.8±26.5   70.4±58.9 0.029
a   32.8±29.7   58.0±30.9   81.7±45.3 0.015
a
　TZV (g)   17.7±10.2   23.4±18.8   41.9±30.6 0.014
a   26.6±21.0   31.3±26.9   55.6±38.5 0.022
a
　TZI  NS NS NS NS   0.53±0.27   0.62±0.19   0.78±0.11 0.036
a
　IPP (mm) 13.3±5.2 17.0±3.1 20.5±8.4 0.035
a NS NS NS NS
　PVR (ml)   48.0±34.1   51.2±49.6   50.7±48.7 0.214
a   51.0±54.1   46.2±37.6   61.2±50.7 0.066
a
　Qmax (ml/s) 12.3±4.2   9.6±3.7   6.1±5.9 0.017
a 11.0±7.3   8.8±5.2   6.3±4.4 0.032
a
　AUR history  11 (8.2) 25 (23.2) 53 (42.7) 0.000
c 18 (16.4) 41 (26.1) 40 (40.8) 0.000
c
Surgical patients ＜0.5 
(n=71)
0.5-0.7 
(n=48)
＞0.7 
(n=43)
＜10 mm 
(n=64)
10-20 mm 
(n=51)
＞20 mm 
(n=47)
　PdetQmax 
(cm H2O)
  65.2±39.0   74.6±30.1   83.8±45.8 0.022
a   77.4±29.8   75.1±39.2   78.6±34.2 0.078
a
　BOOI    50.9±22.8   60.4±28.5   72.3±25.1 0.028
a   53.6±31.7   58.8±37.0   64.9±34.4 0.041
a
　BCI 126.1±33.8 129.8±35.4 118.7±28.0 0.164
a 125.6±20.9 123.7±33.2 118.1±21.4 0.356
a
Values are presented as mean±SD, median (range) or number (%).
TZI, transitional zone index; IPP, intravesical prostatic protrusion; T-PSA, total prostate-specific antigen; IPSS, International Prostate
Symptom Score; QOL, quality of life; TPV, total prostate volume; TZV, transitional zone volume; IPP, intravesical prostatic protrusion;
PRV, postvoiding residual volume; Qmax, maximum urinary flow; AUR, acute urinary retention; PdetQmax, pressure of detrusor at 
Qmax; BOOI, bladder outlet obstruction index; BCI, bladder contractility index. 
a: One-way analysis of variance, 
b: Kraskal-Wallis test, 
c: Pearson Chi-square test.Korean J Urol 2012;53:253-257
256 Huang et al
TABLE 3. Model summary of multiple linear regression with the parameters from TRUS and urodynamics
Qmax PdetQmax BOOI
Standardized 
coefficients
p-value
Standardized 
coefficients
p-value
Standardized 
coefficients
p-value
TPV -0.729 0.490 0.136 0.052 0.394 0.159
TZV -0.747 0.502 0.017 0.077 0.560 0.122
TZI -0.630 0.004 0.809 0.013 0.702 0.028
IPP -0.821 0.038 0.524 0.059 0.028 0.043
PRV -0.058 0.223 0.021 0.039 0.142 0.640
R Square 0.955 0.943 0.826
TRUS, transrectal ultrasonography; Qmax, maximum urinary flow; PdetQmax, pressure of detrusor at Qmax; BOOI, bladder outlet 
obstruction index; TPV, total prostate volume; TZV, transitional zone volume; TZI, transitional zone index; IPP, intravesical prostatic 
protrusion; PRV, postvoiding residual volume.
(Table 3). 
DISCUSSION
The pathophysiology of BPH is complex. Prostatic ad-
enoma enlargement increases urethral resistance and 
leads to BOO, further resulting in compensatory changes 
in bladder function. However, the elevated detrusor pres-
sure required to maintain urinary flow in the presence of 
increased outflow resistance occurs at the expense of nor-
mal bladder storage function, which is the source of DO. 
With the continuation of obstruction, decompensation of 
the detrusor and DUA will eventually take place. The de-
gree of BOO is correlated with the severity of obstruction-rel-
evant symptoms, and the recovery of BOO is used to eval-
uate the efficacy of treatment of BPH. Furthermore, the 
baseline degree of BOO was recently found to influence the 
outcome of treatment. Research has shown that patients 
with BOO have better outcomes from TURP than do those 
without BOO [11-14]. One research study showed that pa-
tients with BOO will still have a favorable surgical outcome 
even if they have DO or DUA [14]. Therefore, some hospi-
tals use urodynamics as a routine preoperative examina-
tion to confirm whether the candidates have explicit BOO 
and good detrusor contractility. However, urodynamic 
study is not totally innocuous, with significant evidence of 
discomfort and urinary infections associated with perform-
ing the examination, as well as imposing additional cost to 
the patient or to the institution. For this reason, some re-
search has been initiated to find less-invasive or non-
invasive examinations for evaluating the degree of BOO. 
IPP measured as the shortest distance connecting the pro-
truded end of the prostate into the bladder based on the 
bladder neck in the sagittal plane reflects the maximum 
longitudinal length of the prostate and may help in assess-
ing the obstructive level of the prostate. Nose et al. [15] first 
studied the correlation between IPP and the BOOI in 30 
male outpatients in 2005 and found that IPP grading corre-
lated well with the BOOI. Keqin et al. [16] analyzed 206 
BPH patients classified by different IPP grade and found 
that the IPP value positively correlated with TPV, PSA, 
PVR, Qmax, PdetQmax, and BOOI as well as the incidence 
of AUR, bladder trabeculation, detrusor overactivity, and 
low bladder compliance. Ku et al. [17] analyzed 260 men 
with LUTS and found that the BOOI was higher in patients 
with apparent IPP than in those without. The TZI calcu-
lated as TZV divided by TPV may also correlate with the 
obstructive level because higher volumes of the transition 
zone will result in harder pressure on the urethra. Kaplan 
et al. [18] evaluated 61 men with symptomatic BPH and 
found a significant correlation between TZI and symptoms, 
Qmax, and PdetQmax. Wang et al. [19] analyzed 116 BPH 
patients and found that TZI and TZV were both positively 
correlated with BOOI and IPSS. Milonas et al. [20] re-
ported that lower TZI was an independent predictor of in-
effective surgical outcome. In the present study, we found 
significant correlations in surgical patients between both 
TZI and IPP with parameters reflecting the level of BOO, 
such as Qmax, PdetQmax, and BOOI. These results are 
consistent with the results of former research and suggest 
that TZI and IPP may be appropriate parameters in diag-
nosing and classifying BOO. For a long period, TURP has 
been the gold standard surgical procedure based on the con-
cept of removing the whole enlarged adenoma involved in 
static and dynamic urethral obstruction. However, the de-
velopment of medication such as alpha-adrenergic block-
ers and 5-alpha-reductase inhibitors has decreased the 
progression of BPH and the operation rate in patients in 
recent years. However, some patients cannot achieve fa-
vorable recovery from drug therapy and need a surgeon to 
relieve the symptoms. The patients needing surgical ther-
apy in our research were found to have higher values of both 
IPP and TZI than the patients needing only drug therapy. 
This result suggests that IPP and TZI could measure the 
disease progression in BPH patients receiving medication 
and might have predictive value for medication efficacy. 
Higher IPP grade was found to correlate with higher void-
ing symptom score, which demonstrated that IPP could re-
flect the severity of BPH from not only an objective aspect 
but also a subjective aspect. AUR is one of the most serious 
complications of BPH and an indication for surgical 
intervention. This research has found positive correlations Korean J Urol 2012;53:253-257
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between not only IPP but also TZI and the incidence of AUR, 
which further suggests that these 2 factors might be used 
to predict the progression of BPH and the possibility of un-
dergoing surgical therapy.
CONCLUSIONS
In general, this research investigated TZI and IPP from 
TRUS in BPH patients and found positive correlations be-
tween these indexes and symptoms, BOO level, and the in-
cidence of AUR. TZI and IPP were also found to differ sig-
nificantly between BPH patients receiving medication and 
those undergoing surgical therapy. The results demon-
strated that the two parameters had favorable value for as-
sessing severity and progression in patients with BPH. 
However, this research was retrospective only, with in-
evitable bias from subject selection and follow-up time. 
Therefore, more prospective research should be launched 
to investigate the predictive value of the two parameters 
for the progression and treatment efficacy of BPH. 
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